Covid vaccine: Single-dose Sputnik Light gets DCGI nod for emergency use

India gets a ninth Covid vaccine as the country’s drug regulator approved the use of Sputnik Light or the single dose regime of Sputnik V for use in the country, the union health minister Mansukh Mandaviya said.

He said in a tweet on Sunday that the Drugs Controller General of India (DCGI) has granted emergency use permission to single-dose Sputnik Light Covid-19 vaccine in India.

“This is the 9th #COVID19 vaccine in the country. This will further strengthen the nation’s collective fight against the pandemic,” the minister said in his tweet.

DCGI has granted emergency use permission to Single-dose Sputnik Light COVID-19 vaccine in India.

This is the 9th #COVID19 vaccine in the country.

This will further strengthen the nation’s collective fight against the pandemic.

— Dr Mansukh Mandaviya (@mansukhmandviya) February 6, 2022

Dr Reddy’s Laboratories (DRL) is the marketing partner for Sputnik vaccines from Russia here. There are several Indian manufacturing partners for the vaccine including Serum Institute of India, Panacea Biotec, Hetero among others.

Sputnik V is a heterogeneous vaccine which uses two different components in its two doses – Ad26 and Ad5. Sputnik Light is the first dose of Sputnik V.

So far, 1.2 million Sputnik V have been administered to Indians, according to Cowin data. The vaccine is available in the private channel only, and the Centre has not procuree it for free vaccinations.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor